Closed Joint Stock Company "Inter YuNA"

Rostov-on-Don

0 studies enrolling now · 1 studies all time

What they study most

Age Related Macular Degeneration

Studies at this site

• Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD — Completed